IL1B and inflammatory bowel disease: Moreover, a sustained increased expression of IL-1β and TNF-α has been reported in several cases of chronic local inflammation, as in rheumatoid arthritis and inflammatory bowel diseases, where the anticytokine therapy is very effective, reducing symptoms and slowing or arresting tissue damage [41].